Recent advancements in diabetes treatment have brought forth a new generation of drugs known as GLP-1 receptor agonists. These substances work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a hormone that https://opensocialfactory.com/story24278904/glp-1-receptor-agonists-retaglutide-retatrutide-and-tirzepatide